Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer

NCT04981509 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

65

Enrollment

NIH

Sponsor class

Conditions

Hereditary Leiomyomatosis and Renal Cell Carcinoma
Papillary Renal Cell Carcinoma
Renal Cell Carcinoma
Sporadic Papillary Renal Cell Carcinoma
Stage III Renal Cell Cancer AJCC v8
Stage IV Renal Cell Cancer AJCC v8

Interventions

BIOLOGICAL: Atezolizumab
BIOLOGICAL: Bevacizumab
PROCEDURE: Biopsy Procedure
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Scan
PROCEDURE: Computed Tomography
PROCEDURE: Computed Tomography with Contrast
DRUG: Erlotinib
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
DRUG: Sodium Fluoride F-18

Sponsor

National Cancer Institute (NCI)